Background-Nasal polyposis often coexists with asthma in airway inflammatory conditions characterised by the infiltration of a range of immune cells. A potentially important role for ovarian hormones has been implicated in airway inflammation but the cellular target for such action is not known. (Thorax 2001;56:205-211) 
Nasal polyposis and asthma are inflammatory diseases of the upper and lower airways, respectively. Both have strikingly similar pathologies and can coexist within the same patient. The inflammatory basis for asthma is well established as being due to microvasculature constrictions causing resultant oedema and reduced respiratory function. 1 2 Likewise, nasal polyps are characterised by infiltration of a wide range of inflammatory cells including mast cells, eosinophils, activated T cells, and macrophages. [3] [4] [5] Current literature suggests that both age and oscillations of sex hormone levels may exacerbate the clinical symptoms of asthma. [6] [7] [8] [9] [10] [11] Women constitute more than 70% of all adult hospital admissions for asthma. 10 11 Sudden death from premenstrual asthma has been observed in two sisters. 12 Previous work has shown an accelerating eVect of exogenous oestrogens on the development of induced hypersensitivity within an animal model, 13 although the target cells and underlying mechanism for the sex hormone eVect remain unclear.
There have been only limited studies of the eVects of sex hormones in airways. In the lung, oestradiol administration increased receptor density which was restored to control values by progesterone 14 ; however, withdrawal of progesterone may be associated with decreased smooth muscle relaxation. 8 Such data are conflicting and fail to resolve important issues such as possible receptor involvement and order of action. It would appear that no study has been carried out to demonstrate the presence of sex hormone receptors within airways. This, despite evidence from studies of other organs showing that sex hormone exposure and antagonistic blockade can regulate peritoneal mast cell release of histamine 15 and its inhibition within peripheral basophils 16 in a dose dependent manner. However, expression of oestrogen receptors within bladder mast cells has been demonstrated by immunohistochemical analysis. 17 In contrast, earlier studies reported specific oestrogen binding sites, using whole cell assays or dextran coated charcoal adsorption (DCC) method, on human peripheral T suppressor/cytotoxic subsets 18 and on mouse peritoneal macrophages. 19 These earlier reports still dominate studies of sex hormone related diseases 20 21 where the interaction between the immune system and plasma oestrogen/progesterone may predispose women to the higher incidence of a range of inflammatory, allergic, and autoimmune diseases. With the current availability of both monoclonal and polyclonal antibodies against oestrogen receptors (ER) and progesterone receptors (PR), together with stringent immunohistochemical techniques, it should now be possible to detect and resolve sites for sex hormone receptors in the upper airways.
The aims of this present study are threefold: (1) to use immunohistochemistry to identify sites for sex hormone receptors within nasal polyp tissue; (2) to define which cell types express such receptors; and (3) to use high aYnity antibodies to assess any gross sex diVerence within a defined population.
Methods
Nasal polyps were obtained by consent from 47 patients (20 men) of mean age 45 years (range 12-76) who underwent elective surgery for nasal obstruction at the Department of Otorhinolaryngology, Second Teaching Hospital, Norman Bethune University, Changchun, China. All patients were non-smokers and had taken neither steroids nor antibiotics during the month before surgery. Continued samples were obtained from the Department of Histopathology, Antrim Area Hospital, Northern Ireland. All specimens were fixed in 10% neutral buVered formalin (1.5 hours), washed in buVer, and processed for wax embedded histological examination. Individual wax sections (5 µm thick) were adhered to 3-aminopropyltriethoxylilane coated (APES) microscope slides and allowed to air dry. IMMUNOHISTOCHEMISTRY with Texas Red or, for immune cell morphology, with DAB. After rinses and an additional blockage with normal horse serum (20 minutes, room temperature), mouse monoclonal antibody (AER311 for ER) incubation was carried out (1 hour, 37°C) before detection with fluorescence linked horse anti-mouse antibody (40 minutes, room temperature, 1:100 diluted TBS). All samples were mounted in Citifluor AF1 (Agar Scientific Ltd, Cambridge, UK) and stored in the dark at 4°C until they could be analysed. Immunofluorescent and bright field results were read using a Nikon Optiphot II Microscope equipped with an epifluorescent mercury lamp source. Images were captured with image analysis software (Imagedok II; Kinetic Imaging Ltd, Liverpool, UK) interfaced to a single chip CCD camera (Hitachi Corp Ltd). The filters used were 31005D605 (Chroma Technology Corp, Liverpool, UK) for Texas-Red and 31001 605 (Chroma Technology Corp) for fluorescein. Low magnification surveys of the main tissue compartments (mucosa, submucosa, glandular epithelium, blood vessels) were carried out and sites for tissue reactivity scored. Higher magnification fields of view (×60) were selected by random tesselation and cell counts were performed for ER positive cells (five fields in total). Cell counts of three or more (mean 
Results

IMMUNOHISTOCHEMICAL REACTIVITY FOR ER OR PR STAINING AND ITS CO-LOCALISATION WITH TISSUE MAST CELLS IN NASAL POLYPS
The results show that upper airway nasal polyps contain cells which label in a positive fashion for both ER and PR (fig 1a, b, c) . The immunoreactive cells to ER or PR are all mononuclear, typically 8-12 µm in diameter, and are characterised by a distinct cytoplasm densely reactive for DAB (fig 1, insert) . Consecutive sections (fig 2) show that cell projections can be "mapped" into at least one adjacent plane. Thus, sites positive for ER appear to be like mast cells in adjacent sections when stained with toluidine blue. The high degree of tissue registration found to exist between ER positive and toluidine blue positive cellular elements appears consistent with tissue reactivity being due to stromal mast cells. 8) (each reported by a diVerent fluorochrome) and imaged using interference filters show the two signals to coexist within the same cell. Exclusion of other possible signal sources appears complete when DAB staining for immune cell morphology fails to exhibit ER immunofluorescence while other cells from within the same section are immunopositive ( fig 9) . Indeed, similar results have been obtained here from three peripheral blood samples (randomly selected from patients presenting with nasal polyps or rhinitis) and two bone marrow trephines from a 48 year old male patient with myeloproliferative disorder (data not shown).
MORE THAN 95% OF MAST CELLS EXPRESS ER/PR IN NASAL POLYPS
The numerical relationship between sex hormone receptor sites and mast cell number was investigated using consecutive sections from 47 subjects. The first section (plane 0) was stained for ER or PR and the adjacent "look up" plane stained with toluidine blue. Area matched fields of view were selected within the submucosa at low magnification and cell counts carried out using a 60:1 lens. When analysed using a two tailed Pearson bivariate correlation test, the correlation between ER or PR positive cells and mast cells was 0.973 (p<0.001) and 0.955 (p<0.001), respectively. Despite the high correlation it would appear that not all mast cells sampled in this study are positive for ER or PR. In pursuit of mast cells negative for both hormone receptor sites, 21 randomly selected ER positive sections were stained for varying time periods with toluidine blue. Although absorption characteristics for receptor site positive cells shifted towards the longer region of the spectrum, typical toluidine blue positive cells could only be found in six of the 21 cases investigated. Here immuno-negative, toluidine blue positive mast cells (fig 6c) accounted for only 2.77 (1.6)% of cells (n=6).
NUMEROUS ER/PR POSITIVE MAST CELLS EXIST IN NASAL POLYPS INDEPENDENT OF SEX AND AGE
Approximately 62% of all samples examined (29 of 47 patients) were positive for ER and above the threshold for cell counts. Positive expression for PR was recorded in approximately 60% of cases (28 of 47 patients). Cases with high expression for sex hormone receptor (fig 1a, b and fig 6a,  b) . Counterstained with HE. Magnification (a) ×10, (b) ×100. (a) ×10, (b) ×100, (c) ×60. sites accounted for 24 patients for ER and 20 patients for PR.
Figure 5 ParaYn embedded section of a human nasal polyp. Only the cells immunohistochemically labelled by monoclonal antibody AA1 for mast cell tryptase were morphologically identical to the cells marked with antibodies for ER
Figure 6 Nasal polyp tissue exhibiting a positive reaction for high aYnity monoclonal antibody against ER (AER311). Distribution of positive cells (a) appears similar to fig 1 and higher magnification detail (b) of the area indicated by a black arrow defines positive cells to be distinct cytoplasmic staining mononuclear cells. Toluidine blue counterstaining of such tissue section reveals that some mast cells (indicated by a red arrow) develop a typical basophilic cytoplasmic staining pattern (c) representative of cells previously negative for ER immunostaining. Magnification
To see if the expression of ER or PR is subject to a sex related eVect, the scores for men and for women were compared in 18 age matched cases (women, mean (SD) age 31.2 (6.3) years, range 22-42 years, n=9; men, mean (SD) age 32.4 (6.0) years, range 21-42 years, n=9). In men the mean (SE) score was 8.4 (1.24) for ER positive cells and 7.7 (1.43) for PR positive cells, while in women the mean (SE) scores were 7.4 (1.7) and 6.3 (1.6) for ER positive and PR positive cells, respectively. Neither ER (p=0.620) nor PR (p=0.517) expression was dependent on patient sex.
To see if the expression of ER or PR can be influenced by age, comparisons were made between diVerent age groups (mixed sexes). The results are shown in table 2. Again, the expression of ER or PR did not vary with patient age. Thus, the total number of receptor site positive mast cells does not vary significantly with sex or age.
Discussion
Demonstration of ER in tissues has been achieved by three approaches: DCC, enzyme immunoassay (EIA), and immunohistochemistry. The latter technique is considered to be superior to others because it allows in situ demonstration of ER, so that the possibility of sample contamination by non-relevant cells or tissue, which is possible with DCC, is excluded. 24 Using immunohistochemistry, the present study has shown that nasal polyp tissues contain numerous ER and/or PR positive cells. These ER and/or PR positive cells were identified as being restricted to mast cells only by parallel toluidine blue staining for mast cells on serial sections and dual immunostaining using high aYnity antibodies for ER or PR and for CD4+, CD8+, CD68+, or mast cell tryptase. This finding not only provides for the first time site specific evidence for the reported sex hormone eVect in airways, [6] [7] [8] [9] [10] [11] [12] [13] but may aid understanding of the possible mechanisms by which these eVects are mediated.
Mast cells are key eVector cells in a variety of allergic disorders and chronic inflammatory diseases including nasal polyposis and asthma. It is well known that degranulation of mast cells leads to both microvascular and cellular responses, causing contractions and rapid oedema of smooth muscles and mobilising other inflammatory cells to enter the inflammatory site. 2 25 The more recent discovery that mast cells are sources of cytokines 26 which play key roles in signal transduction and communication between immune cells suggests that mast cell activation could influence the development of T and B cell responses. 27 Mast cells may also be necessary for activation and regulation of eosinophil 28 and macrophage functions. 29 Hence, our finding of expression of ER/PR by mast cells alone-but not lymphocytes, macrophages or other immune cells-expanding the functional implications of mast cells, suggests that mast cells may be the primary target responsible for sex hormone eVects in airways.
Although earlier studies reported specific oestrogen binding sites using the whole cell culture or DCC method on the human peripheral T suppressor/cytotoxic subset 18 and on mouse peritoneal macrophages, 19 more recent studies with immunohistochemistry have shown diVerent results. Pang et al demonstrated bladder mast cell expression of high aYnity oestrogen receptors in patients with interstitial cystitis. 17 King et al 30 also reported that neither lymphocytes, macrophages, nor a distinctive population of natural killer cells express oestrogen receptors in uterine mucosa. Our data with nasal polyposis tissues are in line with these findings. Indeed, we obtained the same results with peripheral blood smears and bone marrow trephine tissues in the present study. .001 for PR) showed that more than 95% of mast cells sampled in this study express ER and/or PR. The fact that such a considerable number of mast cells express ER/PR in nasal polyp tissues suggests that this may be a major route for the involvement of sex hormones in the development of nasal polyposis and asthma when exposed to a high and fluctuating sex hormone environment.
Functional heterogeneity of human airway mast cells has been reported from diVerent microenvironments within human nasal polyp tissue. 23 The distribution and numbers of mast cells within human nasal polyps can be altered by diVerent fixation. 5 Most stromal mast cells are formalin resistant and contain both tryptase and chymase; on the other hand, most epithelial mast cells are formalin sensitive, tryptase positive, and chymase negative. 5 23 Since the specimens used in this study were formalin fixed tissues, the majority of mast cells sampled are assumed to be of the formalin resistant population. It is noteworthy that the expression of ER and/or PR by mast cells was independent of patient sex and age and that fewer than 5% of the mast cells sampled in this study were negative for ER and/or PR.
Although this study provides compelling evidence that numerous ER and/or PR positive mast cells exist in nasal polyp tissues independent of patient sex and age, further study is indicated to determine whether the ER/PR positive cells are subject to the functional heterogeneity of human airway mast cells and whether there are diVerences in functional form of ER/PR between sexes, ages, or between asthmatic subjects whose symptoms remain unchanged and those who experience alteration in their asthmatic severity in relation to ovarian hormones. We expect these data will be useful in understanding the eVects of sex hormones in airways and in the discovery of suitable synthetic steroid derivatives for clinical use in sex hormone related inflammatory/autoimmune diseases including nasal allergy and asthma. 
